These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17245476)

  • 1. Metabolic domino: new concept in lifestyle medicine.
    Itoh H
    Drugs Today (Barc); 2006 Dec; 42 Suppl C():9-16. PubMed ID: 17245476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What is 'metabolic domino effect'?--new concept in lifestyle-related diseases].
    Itoh H
    Nihon Rinsho; 2003 Oct; 61(10):1837-43. PubMed ID: 14577312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension as part of the metabolic syndrome.
    Cheung B
    J Hum Hypertens; 2008 Dec; 22(12):871-4. PubMed ID: 18548089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnicity and genetics are more important than diabetes mellitus and hypertension in producing cardiovascular events in patients with the metabolic syndrome: emphasis in the Puerto Rico population.
    Altieri PI; Marcial JM; Banchs H; Escobales N; Crespo M
    Bol Asoc Med P R; 2013; 105(3):56-63. PubMed ID: 24282924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Exercise for prevention of osteoporosis and other lifestyle-related diseases].
    Suzuki T
    Clin Calcium; 2011 May; 21(5):722-9. PubMed ID: 21532123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic mild inflammation links obesity, metabolic syndrome, atherosclerosis and diabetes].
    Andel M; Polák J; Kraml P; Dlouhý P; Stich V
    Vnitr Lek; 2009; 55(7-8):659-65. PubMed ID: 19731872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome and cardiovascular disease - an ongoing tsunami.
    Hanefeld M; Pistrosch F
    Pediatr Endocrinol Diabetes Metab; 2013; 20(1):5-11. PubMed ID: 25612864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms for vascular injury in the metabolic syndrome.
    Yamagishi S; Nakamura K; Jinnouchi Y; Takenaka K; Imaizumi T
    Drugs Exp Clin Res; 2005; 31(3):123-9. PubMed ID: 16033251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renin-angiotensin system and metabolic domino].
    Itoh H
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():180-7. PubMed ID: 15813065
    [No Abstract]   [Full Text] [Related]  

  • 14. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
    Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrovascular complications of metabolic syndrome: an early intervention is imperative.
    Tenenbaum A; Motro M; Schwammenthal E; Fisman EZ
    Int J Cardiol; 2004 Nov; 97(2):167-72. PubMed ID: 15458679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatment strategies for patients with hypertension and insulin resistance.
    Kurtz TW
    Am J Med; 2006 May; 119(5 Suppl 1):S24-30. PubMed ID: 16563944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmet needs in controlling metabolic disease.
    Haffner SM
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of the metabolic syndrome.
    Scheen AJ
    Minerva Endocrinol; 2004 Jun; 29(2):31-45. PubMed ID: 15257254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.
    Zhou MS; Schulman IH; Zeng Q
    Vasc Med; 2012 Oct; 17(5):330-41. PubMed ID: 22814999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.